A new trial concludes that bovine colostrum (COL) can reduce risk of upper respiratory tract infections (URTIs) in non-athletic adults at heightened risk of infection, adding to a body of research previously concentrating on athletes.
The European Food Safety Authority (EFSA) has rejected a 13.5 health claim linking Leiber’s beta glucan Yestimun to defence against the common cold, but the company is gearing up for another application after claiming the regulator has been inconsistent.
Japanese probiotics giant Yakult says the writing into law of its rejected EU health claim for upper respiratory tract infection (URTI) benefits won’t alter its core sell in European markets that remained, “stable”.
The author of a high-profile study suggesting that a daily Yakult dose could reduce the incidence and severity of upper respiratory tract infection (URTI) has hit back at criticism of his paper by EFSA (the European Food Safety Authority).
Yakult Europe has signalled its desire to talk to EFSA about the evaluation process and scientific criteria that led to the negative outcome of its proposed health claim on upper respiratory tract health, but pledges to take the decision into account...
Lactobacillus GG (LGG) can decrease the risk of upper respiratory tract infections including rhinitis, pharyngitis, sinusitis, otitis, and the common cold in children attending day care centres, claims a new study.
Taking a daily vitamin E supplement may protect the elderly from
getting colds, suggests a new study, thought to be the first to
demonstrate that vitamin E can protect against colds in a real life
Contrary to widely held views, giving iron supplements to anaemic
children when they have a cold or other upper respiratory tract
infection can improve their iron status without side effects, finds
a recent study.